10 September 2026
Fifth Circuit backs FDA end to GLP-1 shortage listing
Unpublished rulings leave compounders without the shortage exception for copies of Ozempic, Wegovy, Mounjaro and Zepbound.
The full briefing is in the app.
10 September 2026
Unpublished rulings leave compounders without the shortage exception for copies of Ozempic, Wegovy, Mounjaro and Zepbound.
The full briefing is in the app.